Zymetrix has been conducting pre-clinical testing in compliance with the FDA's regulations on Good Laboratory Practice (GLP) for Non-Clinical Laboratory Studies since its inception in 2009. Our laboratory design and our policies and procedures were designed under the guidance of a former FDA inspector with eight years of experience in auditing testing labs. Zymetrix continues to operate with an independent quality assurance group that monitors our testing operations and regularly updates our quality practices. Zymetrix has participated in numerous successful FDA submissions by companies. Please contact us if you would like further information on our GLP.